ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

EIKN // Eikon Therapeutics Inc.

FA <GO> NASDAQ RQD COCKPIT → CIK 0001861123 ↗
Health Care • Biotechnology: Biological Products (No Diagnostic Substances)
$5.35 ▼ -0.19 (-3.43%)
MKT CAP: $289.8M • VOL: 575.8K
EIKN // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
LINE ITEM (USD / %)
FY 2025
FILED 2025-12-31
Revenue (Total Sales) $0
YoY Revenue Growth % —
Gross Profit —
Gross Margin % —
Research & Development (R&D) —
Operating Income (EBIT) $0
Operating Margin % —
Net Income (GAAP) $0
EBITDA (Normalized) —
Diluted EPS ($/sh) —
Operating Cash Flow (OCF) —
Capital Expenditures (CapEx) —
Free Cash Flow (FCF) —
FCF Margin % —
Return on Invested Capital (ROIC %) —
Cash & Short-Term Equivalents $104.9M
Total Debt (Short + Long Term) —
Total Stockholders' Equity -$879.0M